Annual ROE
-29.46%
-74.21%-165.83%
December 31, 2021
Summary
- As of February 10, 2025, LJPC annual return on equity is -29.46%, with the most recent change of -74.21% (-165.83%) on December 31, 2021.
- During the last 3 years, LJPC annual ROE has risen by +330.47% (+91.82%).
Performance
LJPC ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
-5.77%
+1.91%+24.87%
June 30, 2022
Summary
- As of February 10, 2025, LJPC quarterly return on equity is -5.77%, with the most recent change of +1.91% (+24.87%) on June 30, 2022.
- Over the past year, LJPC quarterly ROE has dropped by -2.05% (-55.11%).
Performance
LJPC Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
LJPC ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -165.8% | -55.1% |
| 3 y3 years | +91.8% | +98.6% |
| 5 y5 years | +82.6% | +93.8% |
LJPC ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | +395.8% |
| 5 y | 5-year | -114.2% | at low | -101.1% | +395.8% |
| alltime | all time | -114.2% | +1121.8% | -100.2% | >+9999.0% |
La Jolla Pharmaceutical ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -5.77%(-24.9%) |
| Mar 2022 | - | -7.68%(-73.2%) |
| Dec 2021 | -29.46%(-165.8%) | -28.61%(+70.7%) |
| Sep 2021 | - | -16.76%(+350.5%) |
| Jun 2021 | - | -3.72%(-118.2%) |
| Mar 2021 | - | 20.44%(-59.8%) |
| Dec 2020 | 44.75%(-78.5%) | 50.79%(-42.2%) |
| Sep 2020 | - | 87.90%(-36.2%) |
| Jun 2020 | - | 137.85%(-39.0%) |
| Mar 2020 | - | 225.88%(-55.2%) |
| Dec 2019 | 208.09%(-157.8%) | 504.07%(-136.5%) |
| Sep 2019 | - | -1382.19%(+245.1%) |
| Jun 2019 | - | -400.57%(+61.8%) |
| Mar 2019 | - | -247.56%(+9.0%) |
| Dec 2018 | -359.93%(+113.1%) | -227.20%(+23.4%) |
| Sep 2018 | - | -184.18%(+28.9%) |
| Jun 2018 | - | -142.93%(+27.7%) |
| Mar 2018 | - | -111.91%(+5.0%) |
| Dec 2017 | -168.89%(+86.1%) | -106.60%(+12.3%) |
| Sep 2017 | - | -94.96%(+1.2%) |
| Jun 2017 | - | -93.79%(+6.9%) |
| Mar 2017 | - | -87.77%(+0.1%) |
| Dec 2016 | -90.77%(+72.9%) | -87.64%(+39.6%) |
| Sep 2016 | - | -62.79%(+9.2%) |
| Jun 2016 | - | -57.51%(-3.2%) |
| Mar 2016 | - | -59.44%(-0.0%) |
| Dec 2015 | -52.51%(-51.8%) | -59.46%(-9.6%) |
| Sep 2015 | - | -65.79%(-37.3%) |
| Jun 2015 | - | -104.97%(-2.1%) |
| Mar 2015 | - | -107.17%(-21.2%) |
| Dec 2014 | -108.94%(-53.5%) | -135.97%(-52.4%) |
| Sep 2014 | - | -285.40%(-6.4%) |
| Jun 2014 | - | -304.90%(+0.2%) |
| Mar 2014 | - | -304.24%(-6.2%) |
| Dec 2013 | -234.35%(-2.7%) | -324.37%(-2.1%) |
| Sep 2013 | - | -331.34%(-113.7%) |
| Jun 2013 | - | 2420.79%(+583.9%) |
| Mar 2013 | - | 353.99%(+272.5%) |
| Dec 2012 | -240.73%(-317.3%) | 95.02%(-38.9%) |
| Sep 2012 | - | 155.40%(+24.4%) |
| Jun 2012 | - | 124.93%(-3874.3%) |
| Mar 2012 | - | -3.31%(-102.2%) |
| Dec 2011 | 110.77%(-169.2%) | 151.53%(-338.6%) |
| Sep 2011 | - | -63.50%(-520.5%) |
| Jun 2011 | - | 15.10%(-94.6%) |
| Mar 2011 | - | 279.40%(-191.2%) |
| Dec 2010 | -159.97%(-29.5%) | -306.44%(+2.0%) |
| Sep 2010 | - | -300.52%(+49.6%) |
| Jun 2010 | - | -200.86%(+62.5%) |
| Mar 2010 | - | -123.61%(-26.7%) |
| Dec 2009 | -226.94%(-33.4%) | -168.71%(-42.9%) |
| Sep 2009 | - | -295.60%(+3.1%) |
| Jun 2009 | - | -286.72%(-7.9%) |
| Mar 2009 | - | -311.30%(+11.8%) |
| Dec 2008 | -340.57% | -278.33%(+44.7%) |
| Sep 2008 | - | -192.31%(+33.7%) |
| Jun 2008 | - | -143.81%(+1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | -142.30%(+15.1%) |
| Dec 2007 | -138.56%(+111.2%) | -123.58%(+17.1%) |
| Sep 2007 | - | -105.51%(+16.9%) |
| Jun 2007 | - | -90.22%(+14.4%) |
| Mar 2007 | - | -78.86%(+20.4%) |
| Dec 2006 | -65.62%(+23.7%) | -65.52%(+4.9%) |
| Sep 2006 | - | -62.48%(-2.0%) |
| Jun 2006 | - | -63.77%(-1.3%) |
| Mar 2006 | - | -64.64%(-13.5%) |
| Dec 2005 | -53.06%(-59.2%) | -74.75%(-33.9%) |
| Sep 2005 | - | -113.16%(-0.9%) |
| Jun 2005 | - | -114.20%(+12.0%) |
| Mar 2005 | - | -101.96%(+3.7%) |
| Dec 2004 | -129.89%(+50.9%) | -98.30%(+16.2%) |
| Sep 2004 | - | -84.56%(+15.1%) |
| Jun 2004 | - | -73.48%(-8.6%) |
| Mar 2004 | - | -80.38%(-14.9%) |
| Dec 2003 | -86.09%(+1.7%) | -94.42%(+2.4%) |
| Sep 2003 | - | -92.22%(+4.9%) |
| Jun 2003 | - | -87.89%(+18.0%) |
| Mar 2003 | - | -74.48%(+15.3%) |
| Dec 2002 | -84.65%(+51.4%) | -64.57%(+18.1%) |
| Sep 2002 | - | -54.68%(+14.7%) |
| Jun 2002 | - | -47.68%(+16.0%) |
| Mar 2002 | - | -41.10%(-9.9%) |
| Dec 2001 | -55.92%(+6.5%) | -45.63%(+11.5%) |
| Sep 2001 | - | -40.94%(-8.6%) |
| Jun 2001 | - | -44.78%(-1.5%) |
| Mar 2001 | - | -45.45%(-8.8%) |
| Dec 2000 | -52.53%(-0.4%) | -49.82%(-9.5%) |
| Sep 2000 | - | -55.04%(-7.0%) |
| Jun 2000 | - | -59.20%(+4.9%) |
| Mar 2000 | - | -56.46%(+7.4%) |
| Dec 1999 | -52.74%(+58.9%) | -52.58%(+15.1%) |
| Sep 1999 | - | -45.70%(+9.5%) |
| Jun 1999 | - | -41.75%(+11.7%) |
| Mar 1999 | - | -37.38%(+6.8%) |
| Dec 1998 | -33.19%(+39.0%) | -34.99%(+5.0%) |
| Sep 1998 | - | -33.33%(+7.2%) |
| Jun 1998 | - | -31.10%(+11.3%) |
| Mar 1998 | - | -27.95%(+16.2%) |
| Dec 1997 | -23.88%(-35.9%) | -24.06%(+22.1%) |
| Sep 1997 | - | -19.70%(-26.9%) |
| Jun 1997 | - | -26.94%(-19.5%) |
| Mar 1997 | - | -33.47%(-19.9%) |
| Dec 1996 | -37.28%(-18.9%) | -41.78%(-27.2%) |
| Sep 1996 | - | -57.40%(+22.7%) |
| Jun 1996 | - | -46.78%(-4.6%) |
| Mar 1996 | - | -49.03%(-2.1%) |
| Dec 1995 | -45.99%(-38.4%) | -50.06%(+4.4%) |
| Sep 1995 | - | -47.95%(-21.2%) |
| Jun 1995 | - | -60.82%(-19.8%) |
| Mar 1995 | - | -75.83%(-4.5%) |
| Dec 1994 | -74.64% | -79.38%(+22.9%) |
| Sep 1994 | - | -64.57%(+21.5%) |
| Jun 1994 | - | -53.15%(-33.1%) |
| Mar 1994 | - | -79.49% |
FAQ
- What is La Jolla Pharmaceutical annual return on equity?
- What is the all time high annual ROE for La Jolla Pharmaceutical?
- What is La Jolla Pharmaceutical annual ROE year-on-year change?
- What is La Jolla Pharmaceutical quarterly return on equity?
- What is the all time high quarterly ROE for La Jolla Pharmaceutical?
- What is La Jolla Pharmaceutical quarterly ROE year-on-year change?
What is La Jolla Pharmaceutical annual return on equity?
The current annual ROE of LJPC is -29.46%
What is the all time high annual ROE for La Jolla Pharmaceutical?
La Jolla Pharmaceutical all-time high annual return on equity is 208.09%
What is La Jolla Pharmaceutical annual ROE year-on-year change?
Over the past year, LJPC annual return on equity has changed by -74.21% (-165.83%)
What is La Jolla Pharmaceutical quarterly return on equity?
The current quarterly ROE of LJPC is -5.77%
What is the all time high quarterly ROE for La Jolla Pharmaceutical?
La Jolla Pharmaceutical all-time high quarterly return on equity is 2420.79%
What is La Jolla Pharmaceutical quarterly ROE year-on-year change?
Over the past year, LJPC quarterly return on equity has changed by -2.05% (-55.11%)